Free Trial

Monopar Therapeutics (MNPR) SEC Filings & 10K Form

Monopar Therapeutics logo
$25.82 +2.03 (+8.53%)
(As of 12/20/2024 05:40 PM ET)

Recent Monopar Therapeutics SEC Filings

DateFilerForm TypeView
12/18/2024
4:01 PM
Monopar Therapeutics (Filer)
Form 424B3
12/17/2024
11:15 PM
Monopar Therapeutics (Filer)
Form EFFECT
12/06/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
4:01 PM
Monopar Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/08/2024
7:02 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:01 AM
Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
2:13 PM
JANUS HENDERSON GROUP PLC (Filed by)
Monopar Therapeutics (Subject)
Form SC 13G
10/31/2024
3:17 PM
Monopar Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
10/28/2024
3:04 PM
Monopar Therapeutics (Filer)
Form 424B5
10/28/2024
5:00 AM
ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
Monopar Therapeutics (Subject)
Form SC 13G
10/24/2024
3:08 PM
Monopar Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
10/24/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
6:45 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
6:44 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
3:07 PM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
7:01 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
7:02 AM
Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/22/2024
6:00 AM
Monopar Therapeutics (Filer)
Form DEF 14A
07/22/2024
6:01 AM
Monopar Therapeutics (Filer)
Form ARS
07/11/2024
3:30 PM
Monopar Therapeutics (Filer)
Form PRE 14A
07/09/2024
3:01 PM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
5:20 PM
Monopar Therapeutics (Issuer)
Radhakrishnan Karthik (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2024
5:22 PM
Monopar Therapeutics (Issuer)
Radhakrishnan Karthik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
5:07 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
5:08 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
5:12 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:16 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
5:08 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:30 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
5:12 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:56 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
5:10 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]
05/09/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/16/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
7:33 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
7:33 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
7:35 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
6:01 AM
Monopar Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2024
7:30 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
12:45 PM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
5:59 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
6:36 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:37 PM
Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:38 PM
KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:39 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:40 PM
Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:40 PM
Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:33 PM
Monopar Therapeutics (Issuer)
RIOUX PATRICE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:34 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MNPR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners